Ubrostar 77,2 mg. 171,6 mg. 71 mg Intramammary Suspension

Target species: Cattle (at dry off)

For the treatment of subclinical mastitis at drying off, and the prevention of new bacterial infections of the udder during the dry period in dairy cows, caused by bacteria susceptible to penicillin and framycetin.

Intramammary administration of 100 mg penethamate hydriodide, 280 mg benethamine penicillin and 100 mg framycetin sulphate into each quarter, i.e. the contents of one syringe to be infused into each quarter immediately after last milking of a lactation.

Advice on correct administration:

Before infusion, the teats should be thoroughly cleaned and disinfected, and care should be taken to avoid contamination of the injector nozzle. Following infusion, it is advisable to use a teat wipe or spray.

Do not use in lactating cows.

Do not use in case of hypersensitivity to the active substances or any of the excipients.

Special Warnings:

Where there is a risk of summer mastitis, additional management procedures, such as fly control should be considered.

Special precautions for use

• Special precautions for use in animals: Use of UBROSTAR should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the target bacteria. Official and local antimicrobial policies should be taken into account when the product is used.
• Special precautions to be taken by the person administering the UBROSTAR to animals: Skin sensitisation may occur in persons handling UBROSTAR ; care should be taken to avoid contact with skin. Penicillins and cephalosporins may cause hypersensitivity following injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillins may lead to cross reactions to cephalosporins and vice versa. Allergic reactions to these substances may occasionally be serious.

1. Do not handle UBROSTAR if you know that you are sensitised, or if you have been advised not to work with such preparations.

2. Handle UBROSTAR with care (especially persons with skin damage) to avoid exposure. Wear gloves, wash hands in case of contact with skin.

3. If you develop symptoms such as a skin rash following exposure, seek medical advice and show this warning to your doctor. Swelling of the face, lips or eyes, or difficulty breathing are more serious symptoms and require urgent medical attention.

Pregnancy: Can be used during pregnancy

Lactation: Do not use during lactation

None known. If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon.

Not applicable